溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300381 溢多利

已收盘 08-30 15:00:00

{"stockData":{"symbol":"300381","market":"SZ","secType":"STK","nameCN":"溢多利","latestPrice":5.93,"timestamp":1725001407000,"preClose":5.86,"halted":0,"volume":8598200,"delay":0,"floatShares":486000000,"shares":490000000,"eps":0.0483,"marketStatus":"已收盘","marketStatusCode":5,"change":0.07,"latestTime":"08-30 15:00:00","open":5.84,"high":6.04,"low":5.78,"amount":51099300,"amplitude":0.0444,"askPrice":5.94,"askSize":291,"bidPrice":5.93,"bidSize":799,"shortable":0,"etf":0,"ttmEps":0.0483,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1725240600000},"adr":0,"adjPreClose":5.86,"symbolType":"stock","openAndCloseTimeList":[[1724981400000,1724988600000],[1724994000000,1725001200000]],"highLimit":6.45,"lowLimit":5.27,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":490083367,"pbRate":1.1,"roa":"--","roe":"1.59%","epsLYR":-0.0219,"committee":0.344875,"marketValue":2906000000,"floatMarketCap":2884000000,"peRate":122.774323,"changeRate":0.0119,"turnoverRate":0.0177,"status":0},"requestUrl":"/m/hq/s/300381","defaultTab":"news","newsList":[{"id":"2463656737","title":"溢多利(300381.SZ)与Fornia公司签署技术开发合作合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2463656737","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463656737?lang=zh_cn&edition=full","pubTime":"2024-08-30 20:50","pubTimestamp":1725022233,"startTime":"0","endTime":"0","summary":"智通财经APP讯，溢多利(300381.SZ)公告，公司于2024年8月30日与Fornia BioSolutions,Inc.(简称“Fornia公司”)在广东珠海和美国加州签订了《技术开发合作合同》，约定双方合作开发“用于商业化酶生产的新枯草芽孢杆菌生产菌株平台构建项目和创新型中温alpha-淀粉酶项目”。公司支付的技术开发费金额为250万美元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1177053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0077","BK0070","300381"],"gpt_icon":0},{"id":"2463732665","title":"溢多利最新公告：签订250万美元技术开发合作合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2463732665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463732665?lang=zh_cn&edition=full","pubTime":"2024-08-30 20:35","pubTimestamp":1725021313,"startTime":"0","endTime":"0","summary":"溢多利公告，公司与Fornia公司在广东珠海和美国加州签订了《技术开发合作合同》，约定甲乙双方合作开发“用于商业化酶生产的新枯草芽孢杆菌生产菌株平台构建项目和创新型中温alpha-淀粉酶项目”。经双方协商，本次合作公司向乙方支付的技术开发费金额为250万美元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000045064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0239","BK0077"],"gpt_icon":0},{"id":"2463244231","title":"【机构调研记录】红土创新基金调研华大智造、溢多利","url":"https://stock-news.laohu8.com/highlight/detail?id=2463244231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463244231?lang=zh_cn&edition=full","pubTime":"2024-08-29 08:03","pubTimestamp":1724889792,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月28日披露的机构调研信息，红土创新基金近期对2家上市公司进行了调研，相关名单如下：1）华大智造 个股亮点：公司基因芯片包括规则阵列芯片等核心技术产品；公司研发的远程超声机器人MGIUS-R3应用于远程超声诊断检测。旗下最近一年表现最佳的公募基金产品为红土创新稳健混合A，最新单位净值为1.54，近一年增长6.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900009017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","688114","BK0077","BK0251","BK0070","BK0239"],"gpt_icon":0},{"id":"2462857464","title":"溢多利：8月28日召开分析师会议，首创证券、上海涌贝资产管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2462857464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462857464?lang=zh_cn&edition=full","pubTime":"2024-08-28 22:24","pubTimestamp":1724855052,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年8月28日溢多利发布公告称公司于2024年8月28日召开分析师会议，首创证券、上海涌贝资产管理有限公司、首泰金信(上海)投资管理有限公司、北京千舟千源基金管理有限公司、红土创新基金管理有限公司、粤佛私募基金管理(武汉)有限公司、上海金辇投资管理有限公司、上海贵源投资有限公司、上海度势投资有限公司参与。而此前德国VE由于没有开始销售，公司对其投资收益为负。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800044161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1542","BK1229","09983","BK0070","BK0077","601136","BK1258","BK1583","BK0239","300381","BK0276"],"gpt_icon":0},{"id":"2462157101","title":"溢多利(300381.SZ)发布上半年业绩，净利润4178.35万元，增长464.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462157101","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462157101?lang=zh_cn&edition=full","pubTime":"2024-08-27 18:36","pubTimestamp":1724754960,"startTime":"0","endTime":"0","summary":"智通财经APP讯，溢多利(300381.SZ)发布2024年半年度报告，该公司营业收入为3.97亿元，同比增长3.86%。归属于上市公司股东的净利润为4178.35万元，同比增长464.10%。归属于上市公司股东的扣除非经常性损益的净利润为1887.38万元，同比增长85.36%。基本每股收益为0.0853元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1171953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300381"],"gpt_icon":0},{"id":"2462156861","title":"溢多利最新公告：拟以自有资金对德国子公司增资650万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462156861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462156861?lang=zh_cn&edition=full","pubTime":"2024-08-27 17:15","pubTimestamp":1724750103,"startTime":"0","endTime":"0","summary":"溢多利公告，公司拟以自有资金对德国子公司Victory Enzymes GmbH（德国VE）增资650万欧元，将其注册资本由100万欧元增至750万欧元。本次增资不构成关联交易，不构成重大资产重组。增资后，公司将持有德国VE 93.47%股权。本次增资旨在进一步推进海外市场战略布局，提升在欧洲市场的综合竞争力。投资风险可控，不会对公司财务及经营状况产生不利影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700029962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["EURmain","300381","MEURmain","BK0070","EUO","BK0239","FXE","BK0077"],"gpt_icon":0},{"id":"2462156839","title":"溢多利最新公告：2024年上半年净利润同比增长464.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462156839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462156839?lang=zh_cn&edition=full","pubTime":"2024-08-27 17:14","pubTimestamp":1724750079,"startTime":"0","endTime":"0","summary":"溢多利发布2024年半年度报告，报告期内，公司实现营业收入3.97亿元，同比增长3.86%；归属于上市公司股东的净利润4178.35万元，同比增长464.10%；基本每股收益0.0853元。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700029961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"gpt_icon":0},{"id":"2462598065","title":"溢多利：收购德国子公司剩余49%股权事项相关手续已全部办理完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2462598065","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462598065?lang=zh_cn&edition=full","pubTime":"2024-08-26 10:24","pubTimestamp":1724639093,"startTime":"0","endTime":"0","summary":"中国财富通8月26日 - 溢多利（300381）公告称，为进一步完善海外市场营销网络建设，提高经营决策效率，公司全资子公司VTR\nBiotech PTY Limited（简称“澳洲VTR”）拟以自有资金收购菲托百傲持有的德国VE公司49%股权。截至公告披露日，德国VE股权转让手续已全部办理完毕，菲托百傲不再持有德国VE股权，德国VE股东结构变为上市公司持股51%，澳洲VTR持股49%。德国VE于近日收到德国当地商事登记法院出具的证明文件，德国VE已完成了法定代表人、董事总经理的变更登记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=U2jE9XOESTg%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","300381","BK0070","BK0239"],"gpt_icon":0},{"id":"2461323495","title":"溢多利：公司目前没有开展与猴痘有关的技术或产品研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2461323495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461323495?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:00","pubTimestamp":1724342440,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)08月22日在投资者关系平台上答复投资者关心的问题。投资者：公司有没有猴痘研究溢多利董秘：您好，公司目前没有开展与猴痘有关的技术或产品研究，感谢您的关注。投资者：您好，请问8月20日盘后的股东人数是多少，谢谢！溢多利董秘：您好，截止2024年8月20日，公司股东户数为24960户，感谢您的关注。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300000039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300381","BK0077"],"gpt_icon":0},{"id":"2459531121","title":"溢多利：截止2024年8月9日，公司股东户数为26423户","url":"https://stock-news.laohu8.com/highlight/detail?id=2459531121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459531121?lang=zh_cn&edition=full","pubTime":"2024-08-14 19:03","pubTimestamp":1723633383,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)08月14日在投资者关系平台上答复投资者关心的问题。投资者：请问，贵公司股票，截止到8月9日的股东人数，谢谢！溢多利董秘：您好，截止2024年8月9日，公司股东户数为26423户，感谢您的关注。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400039016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0239","BK0077"],"gpt_icon":0},{"id":"2459942139","title":"溢多利（300381）8月13日主力资金净卖出521.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942139?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:25","pubTimestamp":1723533932,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，溢多利报收于6.21元，下跌1.27%，换手率2.62%，成交量12.72万手，成交额7789.51万元。8月13日的资金流向数据方面，主力资金净流出521.08万元，占总成交额6.69%，游资资金净流出798.99万元，占总成交额10.26%，散户资金净流入1320.07万元，占总成交额16.95%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0239","BK0077"],"gpt_icon":0},{"id":"2458155740","title":"溢多利：公司目前没有生产维生素原料及维生素产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2458155740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458155740?lang=zh_cn&edition=full","pubTime":"2024-08-09 18:05","pubTimestamp":1723197953,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)08月09日在投资者关系平台上答复投资者关心的问题。投资者：公司有生产维生素的原料吗?生产维生素产品吗?溢多利董秘：您好，公司目前没有生产维生素原料及维生素产品，感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900039192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0239","BK0070","BK0077"],"gpt_icon":0},{"id":"2458532977","title":"溢多利（300381）8月9日主力资金净卖出2768.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458532977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458532977?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:22","pubTimestamp":1723188177,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月9日收盘，溢多利报收于6.17元，下跌5.66%，换手率5.67%，成交量27.57万手，成交额1.74亿元。8月9日的资金流向数据方面，主力资金净流出2768.22万元，占总成交额15.94%，游资资金净流出458.64万元，占总成交额2.64%，散户资金净流入3226.87万元，占总成交额18.58%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900025772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300381","BK0070"],"gpt_icon":0},{"id":"2457312860","title":"溢多利（300381）8月7日主力资金净卖出944.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457312860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457312860?lang=zh_cn&edition=full","pubTime":"2024-08-07 15:22","pubTimestamp":1723015375,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月7日收盘，溢多利报收于6.5元，下跌3.7%，换手率4.56%，成交量22.16万手，成交额1.45亿元。8月7日的资金流向数据方面，主力资金净流出944.89万元，占总成交额6.52%，游资资金净流出59.2万元，占总成交额0.41%，散户资金净流入1004.09万元，占总成交额6.93%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700026948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300381","BK0070"],"gpt_icon":0},{"id":"2457497098","title":"溢多利（300381）8月6日主力资金净买入941.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457497098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457497098?lang=zh_cn&edition=full","pubTime":"2024-08-06 15:17","pubTimestamp":1722928636,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月6日收盘，溢多利报收于6.75元，上涨6.47%，换手率7.27%，成交量35.36万手，成交额2.31亿元。8月6日的资金流向数据方面，主力资金净流入941.68万元，占总成交额4.07%，游资资金净流出975.08万元，占总成交额4.22%，散户资金净流入33.39万元，占总成交额0.14%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600024843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0077","BK0070"],"gpt_icon":0},{"id":"2457329718","title":"燃料乙醇概念盘中跳水，溢多利跌8.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457329718","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457329718?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:59","pubTimestamp":1722837574,"startTime":"0","endTime":"0","summary":"08月05日，燃料乙醇概念盘中跳水，截至13点59分，燃料乙醇概念整体指数下跌3.04%，报449.750点。从个股上来看，该概念的成分股中，溢多利跌8.62%，久吾高科、*ST海越、海南椰岛跌幅居前。从资金上来看，截止发稿，燃料乙醇概念主力净流入为-1216.56万，其中*ST海越受到资金热捧，主力净流入79.45万；拉长时间线来看，该板块近20日主力资金净流入1944.10万。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805135934aefd3319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805135934aefd3319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300381","BK0188","BK0012","600387","BK0161","BK0239","BK0077","BK0250","BK0059","BK0028","BK0031","BK0070"],"gpt_icon":0},{"id":"2456424566","title":"溢多利（300381）8月2日主力资金净买入1596.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456424566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456424566?lang=zh_cn&edition=full","pubTime":"2024-08-02 15:16","pubTimestamp":1722582962,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月2日收盘，溢多利报收于6.96元，上涨8.75%，换手率8.61%，成交量41.87万手，成交额2.77亿元。8月2日的资金流向数据方面，主力资金净流入1596.9万元，占总成交额5.76%，游资资金净流入1275.96万元，占总成交额4.6%，散户资金净流出2872.86万元，占总成交额10.36%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200024824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300381","BK0070"],"gpt_icon":0},{"id":"2455350972","title":"溢多利（300381）7月31日主力资金净买入2247.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455350972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455350972?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:27","pubTimestamp":1722410824,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月31日收盘，溢多利报收于6.35元，上涨0.16%，换手率8.44%，成交量41.02万手，成交额2.53亿元。7月31日的资金流向数据方面，主力资金净流入2247.36万元，占总成交额8.9%，游资资金净流入3452.73万元，占总成交额13.67%，散户资金净流出5700.08万元，占总成交额22.57%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100027293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0077","300381"],"gpt_icon":0},{"id":"2455603967","title":"溢多利（300381）7月30日主力资金净买入1456.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455603967","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455603967?lang=zh_cn&edition=full","pubTime":"2024-07-30 15:17","pubTimestamp":1722323857,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月30日收盘，溢多利报收于6.34元，上涨10.26%，换手率7.5%，成交量36.49万手，成交额2.36亿元。7月30日的资金流向数据方面，主力资金净流入1456.7万元，占总成交额6.16%，游资资金净流入2201.19万元，占总成交额9.31%，散户资金净流出3657.9万元，占总成交额15.47%。溢多利主营业务：主要在生物制品行业和生物农牧行业从事生物酶制剂、生物合成品及营养与健康产品的研发、生产、销售和服务,并向客户提供整体生物技术解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000024958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0077","BK0070"],"gpt_icon":0},{"id":"2453759660","title":"溢多利：截止2024年7月20日，公司股东户数为23842户","url":"https://stock-news.laohu8.com/highlight/detail?id=2453759660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453759660?lang=zh_cn&edition=full","pubTime":"2024-07-24 17:06","pubTimestamp":1721811996,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)07月24日在投资者关系平台上答复投资者关心的问题。投资者：您好，请问一下7月20日的股东人数？谢谢溢多利董秘：您好，截止2024年7月20日，公司股东户数为23842户，感谢您的关注。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400039265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","BK0239","300381"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-01-28","address":"广东省珠海市香洲区南屏高科技工业区屏北一路8号","stockEarnings":[{"period":"1week","weight":0.0496},{"period":"1month","weight":-0.0661},{"period":"3month","weight":-0.1484},{"period":"6month","weight":0.1761},{"period":"1year","weight":-0.1685},{"period":"ytd","weight":-0.1877}],"companyName":"广东溢多利生物科技股份有限公司","boardCode":"AI0027","perCapita":"19481股","boardName":"医药制造业","registeredCapital":"49008万元","compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0329},{"period":"3month","weight":-0.0792},{"period":"6month","weight":-0.0611},{"period":"1year","weight":-0.089},{"period":"ytd","weight":-0.0446}],"survey":"　　广东溢多利生物科技股份有限公司一直从事生物酶制剂、甾体激素原料药、功能性饲料添加剂等产品的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司核心产品为饲用酶制剂,包括饲用复合酶、饲用植酸酶和饲用木聚糖酶等。公司及下属子公司分别被评为全国酶制剂十强企业、全国三十强饲料企业、全国饲料科技创新优秀企业、广东和湖南省重点培育和发展的出口名牌，并拥有多项省级名牌产品、著名商标、中国驰名商标等荣誉。","serverTime":1725175451935,"listedPrice":27.88,"stockholders":"24960人(较上一季度减少5.54%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"溢多利,300381,溢多利股票,溢多利股票老虎,溢多利股票老虎国际,溢多利行情,溢多利股票行情,溢多利股价,溢多利股市,溢多利股票价格,溢多利股票交易,溢多利股票购买,溢多利股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}